DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ...

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...

Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging reliance on A1c for diabetes management.

The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) DexCom had made material design changes to its G6 and G7 ...

Medical tech company Masimo (NASDAQ:MASI) will be reporting results this Tuesday after market hours. Here’s what you need to ...

DexCom, a major company in the glucose monitoring market, reported its third-quarter financial results. Although the ...

DexCom’s recent earnings call conveyed a generally positive sentiment, underscored by robust revenue growth and strategic product expansions. The company showcased its advancements in type 2 diabetes ...

Battery Life and Charging: While most flagship smartwatches offer about 18–48 hours of battery life, 2026 models emphasize ...

The DJS Law Group  reminds investors of a class action lawsuit against  Avantor, Inc. ("Avantor " or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule ...

AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast?

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...